#shorts #fortnite ...

there were so many random things in the boxes this week that I’m not entirely sure if I got any of them right. it’s always a ...

After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...

What would a Tesla be without controversy and split opinions? The Tesla Model Y’s midcycle refresh brought significant enough changes to earn it a spot in our 2026 SUV of the Year competition. The ...

Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...

Alongside the withdrawal request, the FDA has also placed a clinical hold on all Intercept clinical trials involving obeticholic acid. Intercept Pharmaceuticals has decided to voluntarily withdraw ...

It's a hat trick. Air Force jets based in Alaska scrambled three times in five days to intercept Russian planes in the Alaska Air Defense Identification Zone. By Nicholas Slayton Published Aug 25, ...